Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 11, 2025

Dec. 11, 2025

Dr. Gregory Facemyer Scholarship Initiative Invests in Next Generation of Preventative Medicine Leadership

EIN Presswire

Dec. 11, 2025

Sienna Announces Offering of $250 Million of 3.524% Series F Senior Unsecured Debentures and Redemption of C$175 Million of Series B Senior Unsecured Debentures

GlobeNewswire

Dec. 11, 2025

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

GlobeNewswire

Dec. 11, 2025

Cycle Pharmaceuticals to Acquire Applied Therapeutics

GlobeNewswire

Dec. 11, 2025

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

GlobeNewswire

Dec. 11, 2025

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

GlobeNewswire

Dec. 11, 2025

Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

GlobeNewswire

Dec. 11, 2025

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

Dec. 11, 2025

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

GlobeNewswire

Dec. 11, 2025

Oruka Therapeutics Announces New Board Member and Board Transition

GlobeNewswire

Dec. 11, 2025

Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results

GlobeNewswire

Dec. 11, 2025

Nusano Receives “Best Companies to Work For” Award from Utah Business

GlobeNewswire

Dec. 11, 2025

Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

Dec. 11, 2025

Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy

GlobeNewswire

Dec. 11, 2025

Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC

GlobeNewswire

Dec. 11, 2025

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

GlobeNewswire

Dec. 11, 2025

Health Care Advocates Slam Ford Government for Privatizing Surgeries While Pushing Public Hospitals into Deficit

GlobeNewswire

Dec. 11, 2025

Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock

GlobeNewswire

Dec. 11, 2025

American Society of Echocardiography Releases 2026 Dates for Live, In-Person Cardiovascular Ultrasound Education Events

GlobeNewswire

Dec. 11, 2025

Sharp Rise in Senior Overdose Deaths Drives Launch of New Healthy Aging Video Program

GlobeNewswire